1 / 16

Sadanandan S. et al. JACC 2004;44:799-803

A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes

Download Presentation

Sadanandan S. et al. JACC 2004;44:799-803

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher P. Cannon, MD**; C. Michael Gibson**; Rajen Desai, MD*; Sabina A. Murphy**, MPH; Peter M. DiBattiste, MD***; Eugene Braunwald, MD** for the TACTICS TIMI-18 Investigators Sadanandan S. et al. JACC 2004;44:799-803

  2. Background • Early combination anti-platelet therapy with aspirin and • clopidogrel is recommended for patients with non-ST • elevation acute coronary syndromes (ACS) • The benefits of combination therapy are apparent within the • first 24 hours with a 300mg loading dose of clopidogrel • However, use of Clopidogrel increases the risk of major • bleeding in patients undergoing early CABG • Available data indicate that 15-25% of patients with non-STE • ACS will require CABG following coronary angiography

  3. Background • Withholding clopidogrel for at least 5 days prior to CABG • reduces the risk of peri-operative bleeding • Such a strategy may impose logistic problems in terms of • prolongation of hospital stay or may impose increased bleeding • risks in pts where early CABG is clinically warranted • Ability to estimate the likelihood for in-hospital CABG using • readily available admission clinical parameters will be useful • This may permit withholding clopidogrel until an early • angiogram (< 24 hours) to define the coronary anatomy or • anticipate CABG and plan withholding Clopidogrel for at least • 5 days prior to CABG

  4. Objective • To develop a simple clinical risk score based on admission • clinical variables to estimate the likelihood of in-hospital • CABG in patients with UA/NSTEMI enrolled in the • TACTICS TIMI-18 trial and • To validate the risk score using UA/NSTEMI patient • population from the TIMI 11B and TIMI 3B trials

  5. TACTICS-TIMI 18 Study Design PCI/ CABG Early Invasive Angio Medical Rx UA/ NSTEMI ASA, Hep,Tirofiban Endpoints Early Conservative Baseline Troponin Medical Rx ETT +ischemia Chest pain Cath/ PCI/ CABG Randomize -24 hrs Hour 0 6 mos 4- 48 108 hrs hrs Cannon CP et al. Am J Cardiol 1998;82:731-6.

  6. Methods: Study Population • We evaluated 2220 pts with UA/NSTEMI randomized to the • early invasive strategy or conservative strategy in the • TACTICS-TIMI 18 study • Patients who underwent CABG following randomization • during initial hospitalization were identified and compared to • patients who did not undergo CABG • Patients with history of prior CABG (N=484) were • significantly less likely to undergo in-hospital CABG (OR • 0.34, p<0.0001) and were excluded

  7. Methods: Study Population • Clinical characteristics of patients who underwent in-hospital • CABG were compared with patients who did not undergo • CABG • A logistic regression model was developed to identify clinical • variables independently associated with in-hospital CABG • A p-value of <0.05 was required for retention in the model • A risk score was generated by assigning numerical scores for • each variable independently associated with in-hospital • CABG

  8. Results: Study population • 2220 pts enrolled in the trial • Of these 362 (16.3%) underwent CABG during index hospitalization • 22% of Invasive Group and 15% of Conservative Group • underwent CABG • The median time to CABG: • Overall population - 3.8 days (2.5, 6.0) • Invasive Group - 3.4 days (1.9, 4.9) • Conservative Group - 5.0 days (3.7, 7.9)

  9. Clinical characteristics of the study groups Characteristics No CABG CABG p-value (N=1857) (N=362) Age (mean years) 61 + 12 63 + 10 0.004 Males (%) 64 74 0.001 Caucasian (%) 77 80 0.3 Hypertension (%) 66 67 0.6 DM (%) 27 33 0.02 Hyperlipidemia (%) 60 63 0.3 Current Smoker (%) 28 27 0.7 Family h/o CAD (%) 43 40 0.3 Prior MI (%) 33 29 0.004 Prior PTCA (%) 28 18 0.0001 Prior CABG (%) 24 10 0.0001 H/o Angina (%) 12 17 0.02 CHF (%) 7 7 0.9 Prior ASA (%) 66 67 0.9 H/o CVA (%) 5.8 4.4 0.3 H/o PAD (%) 7.1 10 0.08 ST Deviation  0.5 mm 36 52 <0.0001 Positive Troponin (%) 55 84 <0.0001

  10. Variables independently associated with CABG – TACTICS TIMI 18 Sadanandan S. et al. JACC 2004;44:799-803

  11. Distribution of CABG Risk Score - TACTICS TIMI-18 Risk score <3 - 42% 3-5 - 55% >5 - 3% N=1828 Frequency (%) Risk score Sadanandan S. et al. JACC 2004;44:799-803

  12. Rates of in-hospital CABG by Increasing Risk Score – TACTICS TIMI 18 N=1828 P<0.0001 C-statistic 0.72 CABG (%) (n) (41 / 763) (221 / 1010) (30 / 55) Risk score Sadanandan S. et al. JACC 2004;44:799-803

  13. Rates of in-hospital CABG by Increasing Risk Score – TACTICS TIMI 18 N=1828 Inv. P<0.0001 C= 0.71 Cons. P<0.0001 C= 0.73 CABG (%) Risk score Sadanandan S. et al. JACC 2004;44:799-803

  14. Validation of association between CABG and Increasing Risk Score – TIMI 11B Trial N=3,722 P<0.0001 C-statistic 0.61 CABG (%) (n) (76 / 1700) (130 / 1692) (38 / 330) Sadanandan S. et al. JACC 2004;44:799-803 Risk score

  15. Validation of CABG Risk Score –TIMI III Registry N=1,139 P<0.0001 C-statistic 0.66 CABG (%) (n) (48 / 1078) (121 / 1628) (57 / 523) Sadanandan S. et al. JACC 2004;44:799-803 Risk score

  16. Conclusions • In patients with UA/NSTEMI, a simple risk score based on admission clinical variables estimates the likelihood of in-hospital CABG • A risk score of >5 is associated with high likelihood of • CABG during index hospitalization • The association between increasing risk score and likelihood of CABG was validated in UA/NSTEMI pt population from TIMI 3Registry and TIMI 11B trials and remained significant • This score may be helpful in timing of clopidgrel therapy for UA/NSTEMI patients Sadanandan S. et al. JACC 2004;44:799-803

More Related